# Commission Implementing Decision of 1 July 2014 authorising the placing on the market of rapeseed protein as a novel food            ingredient under Regulation (EC) No 258/97 of the European Parliament and of the Council (notified under document C(2014)            4256) (Only the German text is authentic) (2014/424/EU)         

        - Previous
        - Next

U.K.

# Commission Implementing Decision

# of 1 July 2014

# authorising the placing on the market of rapeseed protein as a novel food ingredient under Regulation (EC) No 258/97 of the                        European Parliament and of the Council                     

# *(notified under document C(2014) 4256)*

# (Only the German text is authentic)

# (2014/424/EU)

THE EUROPEAN COMMISSION,

Having regard to the Treaty on the Functioning of the European Union,

Having regard to Regulation (EC) No 258/97 of the European Parliament and of the Council of 27 January 1997 concerning novel                           foods and novel food ingredients(1), and in particular Article 7 thereof,                        

Whereas:

(1)On 25 June 2012, the company Helm AG made a request to the competent authorities of Ireland to place rapeseed protein on the                              market as a novel food ingredient. Rapeseed protein is intended to be used as a vegetable protein source in foods except in                              infant formulae and follow-on formulae. On 18 February 2014, the Commission was notified that Siebte PMI Verwaltungs GmbH                              had acquired the rights to the pending request.

(2)On 17 September 2012, the competent food assessment body of Ireland issued its initial assessment report. In that report it                              came to the conclusion that rapeseed protein meets the criteria for novel food set out in Article 3(1) of Regulation (EC)                              No 258/97.

(3)On 4 October 2012, the Commission forwarded the initial assessment report to the other Member States.

(4)Reasoned objections were raised within the 60-day period laid down in the first subparagraph of Article 6(4) of Regulation                              (EC) No 258/97.

(5)On 14 February 2013, the Commission consulted the European Food Safety Authority (EFSA) asking it to carry out an additional                              assessment for rapeseed protein as food ingredient in accordance with Regulation (EC) No 258/97.

(6)On 10 October 2013, in its ‘Scientific Opinion on the safety of “rapeseed protein isolate” as the Novel Food ingredient’(2), EFSA concluded that rapeseed protein is safe as a protein added to food. However, it also noted that the risk of sensitisation                              to rapeseed cannot be excluded and that it is likely that rapeseed can trigger allergic reactions in people allergic to mustard.

(7)Therefore, the opinion gives sufficient grounds to establish that rapeseed protein as a novel food ingredient complies with                              the criteria laid down in Article 3(1) of Regulation (EC) No 258/97, provided that the labelling of foods containing rapeseed                              protein as a food ingredient is such to allow people who are allergic to mustard to avoid consumption of those foods.

(8)The measures provided for in this Decision are in accordance with the opinion of the Standing Committee on the Food Chain                              and Animal Health,

HAS ADOPTED THIS DECISION:

# Article 1U.K.

Rapeseed protein specified in the Annex may be placed on the market in the Union as a novel food ingredient.

# Article 2U.K.

The designation of rapeseed protein authorised by this Decision on the labelling of the foodstuffs containing it shall be                     ‘rapeseed protein’.                  

# Article 3U.K.

The labelling of any foodstuff containing rapeseed protein shall bear an easily visible and legible statement that the product                     containing ‘rapeseed protein’ as a food ingredient may cause allergic reaction to consumers who are allergic to mustard and                     products thereof. Where relevant, this statement shall appear in close proximity to the list of ingredients.                  

# Article 4U.K.

This Decision is addressed to Siebte PMI Verwaltungs GmbH, Neuer Jungfernstieg 5, 20354 Hamburg, Germany.

Done at Brussels, 1 July 2014.

*For the Commission*                            

Tonio Borg                            

*Member of the Commission*                            

## ANNEXU.K.SPECIFICATION OF RAPESEED PROTEIN

**Definition**

:

Rapeseed protein is an aqueous protein-rich extract from rapeseed press cake originating from non-genetically modified *Brassica napus* L. and *Brassica rapa* L.                     

**Description**

:

White to off-white, spray dried powder.

**Purity**

:

**Microbiological criteria**

:

1

OJ L 43, 14.2.1997, p. 1.                           

2

*EFSA Journal* 2013; 11(10):3420.